FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial

2020180 citationsJournal Articlehybrid Open Access

Authors

NCT00433927.

Good health and well-being

Published in: British Journal of Cancer

Volume 124, Issue 3, pp. 587-594

Field-Weighted Citation Impact: 8.79